

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 6.89561310 |
| 2 | urate metabolic process (GO:0046415) | 6.02463087 |
| 3 | regulation of protein activation cascade (GO:2000257) | 5.95328549 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.87654892 |
| 5 | fibrinolysis (GO:0042730) | 5.77720181 |
| 6 | urea metabolic process (GO:0019627) | 5.77340858 |
| 7 | regulation of fibrinolysis (GO:0051917) | 5.66212332 |
| 8 | complement activation, alternative pathway (GO:0006957) | 5.64577389 |
| 9 | regulation of complement activation (GO:0030449) | 5.54746987 |
| 10 | drug transport (GO:0015893) | 5.50358927 |
| 11 | negative regulation of fibrinolysis (GO:0051918) | 5.40419587 |
| 12 | urea cycle (GO:0000050) | 5.39163582 |
| 13 | cellular glucuronidation (GO:0052695) | 5.38205761 |
| 14 | sphingoid metabolic process (GO:0046519) | 5.36395971 |
| 15 | COPI coating of Golgi vesicle (GO:0048205) | 5.33454566 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 5.33454566 |
| 17 | nitrogen cycle metabolic process (GO:0071941) | 5.25643964 |
| 18 | uronic acid metabolic process (GO:0006063) | 5.17551690 |
| 19 | glucuronate metabolic process (GO:0019585) | 5.17551690 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.17332314 |
| 21 | protein carboxylation (GO:0018214) | 5.17332314 |
| 22 | regulation of triglyceride catabolic process (GO:0010896) | 5.00043950 |
| 23 | phenylpropanoid metabolic process (GO:0009698) | 4.99973784 |
| 24 | negative regulation of cholesterol transport (GO:0032375) | 4.99956717 |
| 25 | negative regulation of sterol transport (GO:0032372) | 4.99956717 |
| 26 | epoxygenase P450 pathway (GO:0019373) | 4.97985980 |
| 27 | lysine metabolic process (GO:0006553) | 4.87064697 |
| 28 | lysine catabolic process (GO:0006554) | 4.87064697 |
| 29 | valine metabolic process (GO:0006573) | 4.86041269 |
| 30 | organic cation transport (GO:0015695) | 4.82390568 |
| 31 | beta-amyloid metabolic process (GO:0050435) | 4.80438381 |
| 32 | desmosome organization (GO:0002934) | 4.68417211 |
| 33 | excretion (GO:0007588) | 4.64981342 |
| 34 | blood coagulation, intrinsic pathway (GO:0007597) | 4.60113917 |
| 35 | phosphate ion transport (GO:0006817) | 4.58071400 |
| 36 | phospholipid efflux (GO:0033700) | 4.56265315 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.53730073 |
| 38 | bile acid biosynthetic process (GO:0006699) | 4.52611847 |
| 39 | negative regulation of coagulation (GO:0050819) | 4.47103890 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.43270415 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.43270415 |
| 42 | renal absorption (GO:0070293) | 4.40055501 |
| 43 | response to mercury ion (GO:0046689) | 4.39126612 |
| 44 | negative regulation of protein activation cascade (GO:2000258) | 4.38873393 |
| 45 | peptide catabolic process (GO:0043171) | 4.38033300 |
| 46 | drug metabolic process (GO:0017144) | 4.37900227 |
| 47 | acute-phase response (GO:0006953) | 4.35225503 |
| 48 | oxidative demethylation (GO:0070989) | 4.34552708 |
| 49 | negative regulation of complement activation (GO:0045916) | 4.33677828 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 4.32856990 |
| 51 | tricarboxylic acid metabolic process (GO:0072350) | 4.29211083 |
| 52 | diol metabolic process (GO:0034311) | 4.24543055 |
| 53 | bile acid metabolic process (GO:0008206) | 4.23126463 |
| 54 | alkaloid metabolic process (GO:0009820) | 4.21418479 |
| 55 | sphingosine metabolic process (GO:0006670) | 4.18290757 |
| 56 | ethanol oxidation (GO:0006069) | 4.16105944 |
| 57 | response to phenylpropanoid (GO:0080184) | 4.13862963 |
| 58 | omega-hydroxylase P450 pathway (GO:0097267) | 4.12968505 |
| 59 | negative regulation of wound healing (GO:0061045) | 4.12396410 |
| 60 | branched-chain amino acid metabolic process (GO:0009081) | 4.09654471 |
| 61 | regulation of bile acid biosynthetic process (GO:0070857) | 4.09527821 |
| 62 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.06015398 |
| 63 | glycoside metabolic process (GO:0016137) | 4.04579071 |
| 64 | acylglycerol homeostasis (GO:0055090) | 4.01563018 |
| 65 | triglyceride homeostasis (GO:0070328) | 4.01563018 |
| 66 | short-chain fatty acid metabolic process (GO:0046459) | 3.99318178 |
| 67 | quaternary ammonium group transport (GO:0015697) | 3.97332348 |
| 68 | regulation of plasminogen activation (GO:0010755) | 3.95655116 |
| 69 | glyoxylate metabolic process (GO:0046487) | 3.93087777 |
| 70 | cysteine metabolic process (GO:0006534) | 3.89746876 |
| 71 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.81838079 |
| 72 | protein activation cascade (GO:0072376) | 3.78211910 |
| 73 | bile acid and bile salt transport (GO:0015721) | 3.78159218 |
| 74 | intestinal cholesterol absorption (GO:0030299) | 3.76536321 |
| 75 | polyol transport (GO:0015791) | 3.75249429 |
| 76 | regulation of water loss via skin (GO:0033561) | 3.74229795 |
| 77 | protein-lipid complex remodeling (GO:0034368) | 3.73569227 |
| 78 | macromolecular complex remodeling (GO:0034367) | 3.73569227 |
| 79 | plasma lipoprotein particle remodeling (GO:0034369) | 3.73569227 |
| 80 | high-density lipoprotein particle remodeling (GO:0034375) | 3.70332264 |
| 81 | negative regulation of lipase activity (GO:0060192) | 3.68539598 |
| 82 | * acute inflammatory response (GO:0002526) | 3.67914496 |
| 83 | primary alcohol catabolic process (GO:0034310) | 3.66371838 |
| 84 | ethanol metabolic process (GO:0006067) | 3.65899836 |
| 85 | L-phenylalanine catabolic process (GO:0006559) | 3.65643309 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.65643309 |
| 87 | cellular response to vitamin D (GO:0071305) | 3.63767968 |
| 88 | arginine metabolic process (GO:0006525) | 3.62890225 |
| 89 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.61782858 |
| 90 | L-phenylalanine metabolic process (GO:0006558) | 3.61782858 |
| 91 | regulation of humoral immune response (GO:0002920) | 3.61696740 |
| 92 | cellular modified amino acid catabolic process (GO:0042219) | 3.61114142 |
| 93 | hormone catabolic process (GO:0042447) | 3.61093845 |
| 94 | complement activation (GO:0006956) | 3.58295061 |
| 95 | protein retention in ER lumen (GO:0006621) | 3.57086041 |
| 96 | COPII vesicle coating (GO:0048208) | 3.55723367 |
| 97 | multicellular organismal water homeostasis (GO:0050891) | 3.54882668 |
| 98 | establishment of skin barrier (GO:0061436) | 3.54369080 |
| 99 | retinal metabolic process (GO:0042574) | 3.53625898 |
| 100 | transepithelial transport (GO:0070633) | 3.52058867 |
| 101 | metanephric nephron tubule development (GO:0072234) | 3.51203025 |
| 102 | metanephric tubule development (GO:0072170) | 3.51203025 |
| 103 | complement activation, classical pathway (GO:0006958) | 3.50385060 |
| 104 | flavonoid metabolic process (GO:0009812) | 3.49747654 |
| 105 | glycine metabolic process (GO:0006544) | 3.48946063 |
| 106 | negative regulation of humoral immune response (GO:0002921) | 3.46634720 |
| 107 | phosphate ion transmembrane transport (GO:0035435) | 3.46202859 |
| 108 | branched-chain amino acid catabolic process (GO:0009083) | 3.45267895 |
| 109 | drug catabolic process (GO:0042737) | 3.43788666 |
| 110 | homocysteine metabolic process (GO:0050667) | 3.42900336 |
| 111 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.41926748 |
| 112 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.41926748 |
| 113 | polyketide metabolic process (GO:0030638) | 3.38615620 |
| 114 | doxorubicin metabolic process (GO:0044598) | 3.38615620 |
| 115 | daunorubicin metabolic process (GO:0044597) | 3.38615620 |
| 116 | regulation of lipoprotein particle clearance (GO:0010984) | 3.38154136 |
| 117 | cholesterol efflux (GO:0033344) | 3.36562362 |
| 118 | fatty acid beta-oxidation (GO:0006635) | 3.33786462 |
| 119 | plasma lipoprotein particle clearance (GO:0034381) | 3.32086004 |
| 120 | peptide hormone processing (GO:0016486) | 3.30373791 |
| 121 | aspartate family amino acid catabolic process (GO:0009068) | 3.28503244 |
| 122 | positive regulation of blood coagulation (GO:0030194) | 3.28416999 |
| 123 | positive regulation of hemostasis (GO:1900048) | 3.28416999 |
| 124 | endocrine pancreas development (GO:0031018) | 3.27604845 |
| 125 | steroid catabolic process (GO:0006706) | 3.27560019 |
| 126 | 2-oxoglutarate metabolic process (GO:0006103) | 3.25949747 |
| 127 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.25293131 |
| 128 | serine family amino acid metabolic process (GO:0009069) | 3.24879691 |
| 129 | intestinal epithelial cell development (GO:0060576) | 3.22898807 |
| 130 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.20258409 |
| 131 | sulfur amino acid catabolic process (GO:0000098) | 3.19293720 |
| 132 | metanephric nephron epithelium development (GO:0072243) | 3.18860688 |
| 133 | vitamin D metabolic process (GO:0042359) | 3.18189335 |
| 134 | reverse cholesterol transport (GO:0043691) | 3.17424971 |
| 135 | tyrosine metabolic process (GO:0006570) | 3.16869436 |
| 136 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.16847798 |
| 137 | toxin transport (GO:1901998) | 3.16713706 |
| 138 | fatty acid oxidation (GO:0019395) | 3.14958081 |
| 139 | serine family amino acid biosynthetic process (GO:0009070) | 3.12037038 |
| 140 | exogenous drug catabolic process (GO:0042738) | 3.11814372 |
| 141 | phospholipid scrambling (GO:0017121) | 3.09126740 |
| 142 | primary alcohol metabolic process (GO:0034308) | 3.08654180 |
| 143 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.08640283 |
| 144 | aromatic amino acid family catabolic process (GO:0009074) | 3.08095985 |
| 145 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.07999547 |
| 146 | lipid oxidation (GO:0034440) | 3.07674215 |
| 147 | glandular epithelial cell differentiation (GO:0002067) | 3.05797047 |
| 148 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.04778403 |
| 149 | positive regulation of coagulation (GO:0050820) | 3.04647595 |
| 150 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.03703955 |
| 151 | water homeostasis (GO:0030104) | 3.02879190 |
| 152 | positive regulation of lipid catabolic process (GO:0050996) | 3.02862302 |
| 153 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.02850171 |
| 154 | diterpenoid biosynthetic process (GO:0016102) | 3.02640713 |
| 155 | fructose metabolic process (GO:0006000) | 3.02275899 |
| 156 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.01646342 |
| 157 | proline metabolic process (GO:0006560) | 2.99737802 |
| 158 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.97232892 |
| 159 | positive regulation of extracellular matrix organization (GO:1903055) | 2.96359325 |
| 160 | fucose metabolic process (GO:0006004) | 2.95501584 |
| 161 | phosphate ion homeostasis (GO:0055062) | 2.93024301 |
| 162 | trivalent inorganic anion homeostasis (GO:0072506) | 2.93024301 |
| 163 | cellular ketone body metabolic process (GO:0046950) | 2.89837911 |
| 164 | metanephric epithelium development (GO:0072207) | 2.89357211 |
| 165 | 4-hydroxyproline metabolic process (GO:0019471) | 2.89034299 |
| 166 | cellular response to vitamin (GO:0071295) | 2.88973081 |
| 167 | glutathione biosynthetic process (GO:0006750) | 2.88036198 |
| 168 | positive regulation of nuclease activity (GO:0032075) | 2.87540580 |
| 169 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.85620059 |
| 170 | carnitine transport (GO:0015879) | 2.85349267 |
| 171 | amino-acid betaine transport (GO:0015838) | 2.85349267 |
| 172 | tryptophan metabolic process (GO:0006568) | 2.85140653 |
| 173 | nephron tubule development (GO:0072080) | 2.84149824 |
| 174 | fatty acid catabolic process (GO:0009062) | 2.83158881 |
| 175 | transcytosis (GO:0045056) | 2.80702583 |
| 176 | angiotensin maturation (GO:0002003) | 2.80015169 |
| 177 | regulation of ruffle assembly (GO:1900027) | 2.77135373 |
| 178 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.75869590 |
| 179 | modified amino acid transport (GO:0072337) | 2.74992793 |
| 180 | amino-acid betaine metabolic process (GO:0006577) | 2.74458035 |
| 181 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.70696969 |
| 182 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.70112439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.21915936 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.04488667 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.52263595 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.52043484 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.41224822 |
| 6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.37105695 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.97513435 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.76105865 |
| 9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.71997865 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.57298148 |
| 11 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.46476902 |
| 12 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.29091741 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.13412415 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.13250640 |
| 15 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.06811603 |
| 16 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.06082224 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.04028021 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99133211 |
| 19 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.96401326 |
| 20 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.96233749 |
| 21 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.93221240 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92804874 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.90998531 |
| 24 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.88802472 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.88543153 |
| 26 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.73147510 |
| 27 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.67168135 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.65612650 |
| 29 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.59022836 |
| 30 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.58015236 |
| 31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57762200 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.55241965 |
| 33 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49168077 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48743449 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44517466 |
| 36 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.44227664 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41565046 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40509279 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37553783 |
| 40 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.37470055 |
| 41 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37372983 |
| 42 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35579213 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34764234 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.31391635 |
| 45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29429519 |
| 46 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29052219 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.28064224 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.27295882 |
| 49 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.26345990 |
| 50 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.24061602 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16618102 |
| 52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16618102 |
| 53 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.13834003 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13725248 |
| 55 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11261579 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11065648 |
| 57 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10113338 |
| 58 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08875933 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07962233 |
| 60 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07202394 |
| 61 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06860221 |
| 62 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05654050 |
| 63 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04528403 |
| 64 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03913214 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02399341 |
| 66 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01783960 |
| 67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01783960 |
| 68 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99550115 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98787008 |
| 70 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97923975 |
| 71 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97148940 |
| 72 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97059880 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96969454 |
| 74 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96819362 |
| 75 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96819362 |
| 76 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95367878 |
| 77 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95205771 |
| 78 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94652756 |
| 79 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93864630 |
| 80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92771314 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92507350 |
| 82 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91985101 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91691020 |
| 84 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90092453 |
| 85 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.88807177 |
| 86 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88127595 |
| 87 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86642906 |
| 88 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.86619722 |
| 89 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85917912 |
| 90 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.85568693 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85342453 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84982916 |
| 93 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.84977426 |
| 94 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84819115 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82724079 |
| 96 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82213866 |
| 97 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81561316 |
| 98 | VDR_22108803_ChIP-Seq_LS180_Human | 0.81145912 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80402679 |
| 100 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80402618 |
| 101 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.79537264 |
| 102 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.79537264 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78872514 |
| 104 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.78721680 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78169908 |
| 106 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77661855 |
| 107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77056806 |
| 108 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.76084527 |
| 109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.75959840 |
| 110 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.75726914 |
| 111 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.75430712 |
| 112 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.75370850 |
| 113 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.75186942 |
| 114 | AR_20517297_ChIP-Seq_VCAP_Human | 0.74599223 |
| 115 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.74046565 |
| 116 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.73598747 |
| 117 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.73356280 |
| 118 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.72748787 |
| 119 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.71758601 |
| 120 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.67187591 |
| 121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66621008 |
| 122 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.65262143 |
| 123 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.64183720 |
| 124 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.63762176 |
| 125 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63311524 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.63018573 |
| 127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.62640034 |
| 128 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.62498167 |
| 129 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.62273071 |
| 130 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.59951596 |
| 131 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.59795779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 6.12626587 |
| 2 | MP0003195_calcinosis | 5.00036971 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.79113424 |
| 4 | MP0001765_abnormal_ion_homeostasis | 3.62904880 |
| 5 | MP0005360_urolithiasis | 3.57062164 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 3.38159975 |
| 7 | MP0003868_abnormal_feces_composition | 3.37092869 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.26998391 |
| 9 | MP0002796_impaired_skin_barrier | 3.25147355 |
| 10 | MP0009643_abnormal_urine_homeostasis | 3.19948982 |
| 11 | MP0001756_abnormal_urination | 2.88690743 |
| 12 | MP0009840_abnormal_foam_cell | 2.88167902 |
| 13 | MP0005332_abnormal_amino_acid | 2.77543655 |
| 14 | MP0005636_abnormal_mineral_homeostasis | 2.76969376 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.36080812 |
| 16 | MP0005451_abnormal_body_composition | 2.35363523 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.27402192 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 2.21300986 |
| 19 | MP0003941_abnormal_skin_development | 2.11190566 |
| 20 | MP0000538_abnormal_urinary_bladder | 2.10446283 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.09225529 |
| 22 | MP0003252_abnormal_bile_duct | 2.04693479 |
| 23 | MP0002136_abnormal_kidney_physiology | 2.04431675 |
| 24 | MP0005501_abnormal_skin_physiology | 1.87101431 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.86910578 |
| 26 | MP0005220_abnormal_exocrine_pancreas | 1.82474485 |
| 27 | MP0002009_preneoplasia | 1.81142870 |
| 28 | MP0005365_abnormal_bile_salt | 1.76052504 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.75813397 |
| 30 | MP0008961_abnormal_basal_metabolism | 1.73621560 |
| 31 | MP0003283_abnormal_digestive_organ | 1.72916468 |
| 32 | MP0002132_abnormal_respiratory_system | 1.72338118 |
| 33 | MP0009697_abnormal_copulation | 1.72181435 |
| 34 | MP0005085_abnormal_gallbladder_physiolo | 1.69101787 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.66883042 |
| 36 | MP0004885_abnormal_endolymph | 1.66665227 |
| 37 | MP0002098_abnormal_vibrissa_morphology | 1.65909535 |
| 38 | MP0005310_abnormal_salivary_gland | 1.65904415 |
| 39 | MP0001944_abnormal_pancreas_morphology | 1.64522181 |
| 40 | MP0005275_abnormal_skin_tensile | 1.64506913 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.59284497 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 1.58949451 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.56755264 |
| 44 | MP0002693_abnormal_pancreas_physiology | 1.52606418 |
| 45 | MP0000566_synostosis | 1.47315283 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.45281188 |
| 47 | MP0001666_abnormal_nutrient_absorption | 1.41684477 |
| 48 | MP0005083_abnormal_biliary_tract | 1.33240687 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.33067991 |
| 50 | MP0002909_abnormal_adrenal_gland | 1.32640130 |
| 51 | * MP0010386_abnormal_urinary_bladder | 1.30402683 |
| 52 | MP0002060_abnormal_skin_morphology | 1.25073543 |
| 53 | MP0002896_abnormal_bone_mineralization | 1.22455072 |
| 54 | MP0001216_abnormal_epidermal_layer | 1.19212124 |
| 55 | MP0000230_abnormal_systemic_arterial | 1.18045543 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.14619092 |
| 57 | MP0000537_abnormal_urethra_morphology | 1.12442071 |
| 58 | MP0002837_dystrophic_cardiac_calcinosis | 1.09652675 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.09575863 |
| 60 | MP0004947_skin_inflammation | 1.09427016 |
| 61 | MP0009785_altered_susceptibility_to | 1.09107365 |
| 62 | MP0002089_abnormal_postnatal_growth/wei | 1.07969050 |
| 63 | MP0000377_abnormal_hair_follicle | 1.07257295 |
| 64 | MP0010678_abnormal_skin_adnexa | 1.06497752 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.06364017 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 1.03665852 |
| 67 | MP0006054_spinal_hemorrhage | 1.02829303 |
| 68 | MP0008004_abnormal_stomach_pH | 1.01515320 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 1.01273343 |
| 70 | MP0005535_abnormal_body_temperature | 1.00957607 |
| 71 | MP0010771_integument_phenotype | 0.99356732 |
| 72 | MP0000678_abnormal_parathyroid_gland | 0.97214319 |
| 73 | MP0005023_abnormal_wound_healing | 0.94724008 |
| 74 | MP0004381_abnormal_hair_follicle | 0.93911849 |
| 75 | MP0000613_abnormal_salivary_gland | 0.93389232 |
| 76 | MP0002928_abnormal_bile_duct | 0.93129089 |
| 77 | MP0000579_abnormal_nail_morphology | 0.92051525 |
| 78 | MP0002168_other_aberrant_phenotype | 0.92000627 |
| 79 | MP0003186_abnormal_redox_activity | 0.89224633 |
| 80 | MP0005164_abnormal_response_to | 0.89102602 |
| 81 | MP0001764_abnormal_homeostasis | 0.87629787 |
| 82 | MP0002118_abnormal_lipid_homeostasis | 0.87038331 |
| 83 | MP0005666_abnormal_adipose_tissue | 0.85545193 |
| 84 | MP0003879_abnormal_hair_cell | 0.84051483 |
| 85 | MP0003724_increased_susceptibility_to | 0.83270264 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.82501681 |
| 87 | MP0004147_increased_porphyrin_level | 0.81340046 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.81009193 |
| 89 | MP0005647_abnormal_sex_gland | 0.80985846 |
| 90 | MP0004272_abnormal_basement_membrane | 0.80109861 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.79768459 |
| 92 | MP0001191_abnormal_skin_condition | 0.77035549 |
| 93 | MP0000598_abnormal_liver_morphology | 0.76155605 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.75478656 |
| 95 | MP0008469_abnormal_protein_level | 0.74652294 |
| 96 | MP0005375_adipose_tissue_phenotype | 0.73328192 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72093098 |
| 98 | MP0001346_abnormal_lacrimal_gland | 0.72085808 |
| 99 | MP0000367_abnormal_coat/_hair | 0.71872770 |
| 100 | MP0002135_abnormal_kidney_morphology | 0.71859969 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.70665561 |
| 102 | MP0002254_reproductive_system_inflammat | 0.69838573 |
| 103 | MP0003953_abnormal_hormone_level | 0.68137576 |
| 104 | MP0001958_emphysema | 0.66590320 |
| 105 | MP0003943_abnormal_hepatobiliary_system | 0.66559400 |
| 106 | MP0009764_decreased_sensitivity_to | 0.66406051 |
| 107 | MP0002006_tumorigenesis | 0.66275549 |
| 108 | MP0009763_increased_sensitivity_to | 0.65531175 |
| 109 | MP0004883_abnormal_blood_vessel | 0.65258026 |
| 110 | MP0003011_delayed_dark_adaptation | 0.64891098 |
| 111 | MP0005395_other_phenotype | 0.64723003 |
| 112 | MP0001919_abnormal_reproductive_system | 0.64417477 |
| 113 | MP0003959_abnormal_lean_body | 0.63949898 |
| 114 | MP0005166_decreased_susceptibility_to | 0.63577556 |
| 115 | MP0009642_abnormal_blood_homeostasis | 0.63347061 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.63106814 |
| 117 | MP0005408_hypopigmentation | 0.63037773 |
| 118 | MP0010329_abnormal_lipoprotein_level | 0.62267843 |
| 119 | MP0005670_abnormal_white_adipose | 0.62255988 |
| 120 | MP0002234_abnormal_pharynx_morphology | 0.61850771 |
| 121 | MP0000609_abnormal_liver_physiology | 0.60601623 |
| 122 | MP0003315_abnormal_perineum_morphology | 0.60333372 |
| 123 | MP0001845_abnormal_inflammatory_respons | 0.59898421 |
| 124 | MP0000604_amyloidosis | 0.58423890 |
| 125 | MP0003690_abnormal_glial_cell | 0.57853304 |
| 126 | MP0002971_abnormal_brown_adipose | 0.56979947 |
| 127 | MP0000249_abnormal_blood_vessel | 0.56914920 |
| 128 | MP0001881_abnormal_mammary_gland | 0.56442159 |
| 129 | MP0001873_stomach_inflammation | 0.55521395 |
| 130 | MP0008872_abnormal_physiological_respon | 0.55518326 |
| 131 | MP0003436_decreased_susceptibility_to | 0.54806446 |
| 132 | MP0000467_abnormal_esophagus_morphology | 0.54575956 |
| 133 | MP0001664_abnormal_digestion | 0.54354891 |
| 134 | MP0003638_abnormal_response/metabolism_ | 0.54059839 |
| 135 | MP0002163_abnormal_gland_morphology | 0.52620425 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.52357680 |
| 137 | * MP0005025_abnormal_response_to | 0.48098958 |
| 138 | MP0008874_decreased_physiological_sensi | 0.47965977 |
| 139 | MP0003045_fibrosis | 0.43754546 |
| 140 | MP0003950_abnormal_plasma_membrane | 0.43212821 |
| 141 | MP0001270_distended_abdomen | 0.40512678 |
| 142 | MP0002419_abnormal_innate_immunity | 0.40123974 |
| 143 | MP0001851_eye_inflammation | 0.39830400 |
| 144 | MP0000462_abnormal_digestive_system | 0.39730656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.84001374 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.83729434 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 7.50815696 |
| 4 | Increased circulating renin level (HP:0000848) | 7.10349098 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 6.79991761 |
| 6 | Metabolic alkalosis (HP:0200114) | 6.75029990 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 6.42040602 |
| 8 | Hypomagnesemia (HP:0002917) | 6.34106535 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 6.02941526 |
| 10 | Polyuria (HP:0000103) | 5.80318785 |
| 11 | Abnormal urine output (HP:0012590) | 5.58614264 |
| 12 | Complement deficiency (HP:0004431) | 5.55302109 |
| 13 | Abnormality of magnesium homeostasis (HP:0004921) | 5.38905765 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 5.34929310 |
| 15 | Gout (HP:0001997) | 5.34883161 |
| 16 | Abnormality of renal excretion (HP:0011036) | 5.23577985 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 5.05668673 |
| 18 | Abnormality of renin-angiotensin system (HP:0000847) | 5.00548017 |
| 19 | Abnormal drinking behavior (HP:0030082) | 4.83813653 |
| 20 | Polydipsia (HP:0001959) | 4.83813653 |
| 21 | Hyperaldosteronism (HP:0000859) | 4.67582187 |
| 22 | Alkalosis (HP:0001948) | 4.61124554 |
| 23 | Renal salt wasting (HP:0000127) | 4.55905435 |
| 24 | Hypokalemia (HP:0002900) | 4.48076765 |
| 25 | Tetany (HP:0001281) | 4.45431730 |
| 26 | Abnormality of complement system (HP:0005339) | 4.36586420 |
| 27 | Glomerulonephritis (HP:0000099) | 4.16878369 |
| 28 | Joint hemorrhage (HP:0005261) | 4.09317676 |
| 29 | Ketoacidosis (HP:0001993) | 4.04832823 |
| 30 | Generalized aminoaciduria (HP:0002909) | 3.90923966 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.86800967 |
| 32 | Xanthomatosis (HP:0000991) | 3.81320731 |
| 33 | Intrahepatic cholestasis (HP:0001406) | 3.77905813 |
| 34 | Hyperlipoproteinemia (HP:0010980) | 3.74220625 |
| 35 | Abnormality of potassium homeostasis (HP:0011042) | 3.63300277 |
| 36 | Proximal tubulopathy (HP:0000114) | 3.59400096 |
| 37 | Abnormality of purine metabolism (HP:0004352) | 3.57814810 |
| 38 | Increased purine levels (HP:0004368) | 3.54636242 |
| 39 | Hyperuricemia (HP:0002149) | 3.54636242 |
| 40 | Hyperglycinuria (HP:0003108) | 3.38948811 |
| 41 | Ketosis (HP:0001946) | 3.08851522 |
| 42 | Decreased circulating renin level (HP:0003351) | 3.00808795 |
| 43 | Hypolipoproteinemia (HP:0010981) | 3.00396404 |
| 44 | Nephritis (HP:0000123) | 2.99109019 |
| 45 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.97929950 |
| 46 | Hypoglycemic coma (HP:0001325) | 2.97022240 |
| 47 | Steatorrhea (HP:0002570) | 2.96107816 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.94090569 |
| 49 | Mitral stenosis (HP:0001718) | 2.89935036 |
| 50 | Abnormality of urine glucose concentration (HP:0011016) | 2.83897342 |
| 51 | Glycosuria (HP:0003076) | 2.83897342 |
| 52 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79457561 |
| 53 | Hypoplasia of the uterus (HP:0000013) | 2.75316159 |
| 54 | Dehydration (HP:0001944) | 2.74317948 |
| 55 | Hypercalciuria (HP:0002150) | 2.74258818 |
| 56 | Hyperammonemia (HP:0001987) | 2.71026524 |
| 57 | Reduced antithrombin III activity (HP:0001976) | 2.68438560 |
| 58 | Abnormality of glycine metabolism (HP:0010895) | 2.67832799 |
| 59 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.67832799 |
| 60 | Conjugated hyperbilirubinemia (HP:0002908) | 2.67409010 |
| 61 | Mucopolysacchariduria (HP:0008155) | 2.63386991 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.63386991 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60091025 |
| 64 | Symptomatic seizures (HP:0011145) | 2.56791838 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.52570176 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.52081004 |
| 67 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.50646559 |
| 68 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.45224015 |
| 69 | Hyperphosphaturia (HP:0003109) | 2.44681599 |
| 70 | Hypophosphatemia (HP:0002148) | 2.42788383 |
| 71 | Hyponatremia (HP:0002902) | 2.42408820 |
| 72 | Parakeratosis (HP:0001036) | 2.41364749 |
| 73 | Abnormality of the Achilles tendon (HP:0005109) | 2.40935401 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40644480 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40644480 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40644480 |
| 77 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.39866014 |
| 78 | Hypoalphalipoproteinemia (HP:0003233) | 2.37923293 |
| 79 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.37005228 |
| 80 | Adrenal overactivity (HP:0002717) | 2.36540853 |
| 81 | Late onset (HP:0003584) | 2.36484782 |
| 82 | Renal tubular acidosis (HP:0001947) | 2.32805872 |
| 83 | Abnormality of sodium homeostasis (HP:0010931) | 2.32585890 |
| 84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.30586889 |
| 85 | Widely patent fontanelles and sutures (HP:0004492) | 2.29504752 |
| 86 | Abnormal urine phosphate concentration (HP:0012599) | 2.27697925 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.26935219 |
| 88 | Gangrene (HP:0100758) | 2.26791792 |
| 89 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.24128198 |
| 90 | Hydroxyprolinuria (HP:0003080) | 2.23029685 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.23029685 |
| 92 | Exocrine pancreatic insufficiency (HP:0001738) | 2.21693220 |
| 93 | Rickets (HP:0002748) | 2.18725032 |
| 94 | Focal segmental glomerulosclerosis (HP:0000097) | 2.18630698 |
| 95 | Abnormal pancreas size (HP:0012094) | 2.15006020 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.14538929 |
| 97 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.11678961 |
| 98 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.11207240 |
| 99 | Nephrolithiasis (HP:0000787) | 2.10708791 |
| 100 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.10618431 |
| 101 | Vascular calcification (HP:0004934) | 2.10602417 |
| 102 | Hyperglycinemia (HP:0002154) | 2.09665364 |
| 103 | Hyperkalemia (HP:0002153) | 2.09337738 |
| 104 | Hepatocellular carcinoma (HP:0001402) | 2.08974659 |
| 105 | Hypotension (HP:0002615) | 2.08630898 |
| 106 | Protuberant abdomen (HP:0001538) | 2.07880397 |
| 107 | Erythema (HP:0010783) | 2.07393129 |
| 108 | Delayed epiphyseal ossification (HP:0002663) | 2.06054885 |
| 109 | Potter facies (HP:0002009) | 2.05674972 |
| 110 | Facial shape deformation (HP:0011334) | 2.05674972 |
| 111 | Nephrocalcinosis (HP:0000121) | 2.02226289 |
| 112 | Menorrhagia (HP:0000132) | 2.01617233 |
| 113 | Osteomalacia (HP:0002749) | 2.01282179 |
| 114 | Abnormality of serum amino acid levels (HP:0003112) | 2.00306396 |
| 115 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.99280933 |
| 116 | Enlarged kidneys (HP:0000105) | 1.99085896 |
| 117 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.96453696 |
| 118 | Ileus (HP:0002595) | 1.95635977 |
| 119 | Elevated alkaline phosphatase (HP:0003155) | 1.95223979 |
| 120 | Increased serum ferritin (HP:0003281) | 1.94305893 |
| 121 | Glomerulosclerosis (HP:0000096) | 1.93455300 |
| 122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.92850457 |
| 123 | Abnormal tarsal ossification (HP:0008369) | 1.92658610 |
| 124 | Spontaneous abortion (HP:0005268) | 1.92203523 |
| 125 | Hyperphosphatemia (HP:0002905) | 1.92066240 |
| 126 | Purpura (HP:0000979) | 1.89158797 |
| 127 | Increased IgE level (HP:0003212) | 1.88688167 |
| 128 | Abnormality of the intrinsic pathway (HP:0010989) | 1.88142030 |
| 129 | Chondrocalcinosis (HP:0000934) | 1.85769379 |
| 130 | Cardiovascular calcification (HP:0011915) | 1.84108862 |
| 131 | Delayed CNS myelination (HP:0002188) | 1.83176186 |
| 132 | Fat malabsorption (HP:0002630) | 1.82786008 |
| 133 | Congenital sensorineural hearing impairment (HP:0008527) | 1.81242032 |
| 134 | Abnormal gallbladder physiology (HP:0012438) | 1.80654387 |
| 135 | Cholecystitis (HP:0001082) | 1.80654387 |
| 136 | Pancreatitis (HP:0001733) | 1.79902858 |
| 137 | Hyperparathyroidism (HP:0000843) | 1.79819170 |
| 138 | Metabolic acidosis (HP:0001942) | 1.78864623 |
| 139 | Gingival bleeding (HP:0000225) | 1.78625332 |
| 140 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.76924314 |
| 141 | Abnormality of Sharpey fibers (HP:0100685) | 1.75457474 |
| 142 | Malnutrition (HP:0004395) | 1.75105766 |
| 143 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74524630 |
| 144 | Dicarboxylic aciduria (HP:0003215) | 1.74524630 |
| 145 | Pulmonary embolism (HP:0002204) | 1.74023703 |
| 146 | Thin bony cortex (HP:0002753) | 1.73903501 |
| 147 | Fair hair (HP:0002286) | 1.73315704 |
| 148 | Abnormality of renal resorption (HP:0011038) | 1.71930398 |
| 149 | Vomiting (HP:0002013) | 1.70953470 |
| 150 | Hyperglycemia (HP:0003074) | 1.65334307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 7.11087557 |
| 2 | OXSR1 | 6.22471284 |
| 3 | WNK3 | 5.27355646 |
| 4 | STK39 | 5.20267691 |
| 5 | INSRR | 3.21417565 |
| 6 | STK24 | 2.67308586 |
| 7 | BCKDK | 2.67138190 |
| 8 | MST4 | 2.58516510 |
| 9 | FRK | 2.57487476 |
| 10 | MAP3K2 | 2.35754307 |
| 11 | ERN1 | 2.33321187 |
| 12 | TAOK3 | 2.15607026 |
| 13 | LATS1 | 2.08744724 |
| 14 | MAP3K12 | 2.06915589 |
| 15 | STK38L | 1.92989790 |
| 16 | MST1R | 1.83311288 |
| 17 | FER | 1.75978083 |
| 18 | AKT3 | 1.73533956 |
| 19 | MAP3K3 | 1.53985691 |
| 20 | WNK1 | 1.53047246 |
| 21 | TNK2 | 1.52521063 |
| 22 | TBK1 | 1.47229763 |
| 23 | PRKG2 | 1.38995735 |
| 24 | ABL2 | 1.36440254 |
| 25 | PASK | 1.31140366 |
| 26 | PTK6 | 1.19289702 |
| 27 | MAPK15 | 1.16079159 |
| 28 | SGK223 | 1.07877556 |
| 29 | SGK494 | 1.07877556 |
| 30 | MAPKAPK3 | 1.07219640 |
| 31 | FGFR2 | 1.04406021 |
| 32 | IKBKB | 1.03905351 |
| 33 | PDK2 | 1.03212530 |
| 34 | MET | 0.98153379 |
| 35 | TAOK2 | 0.97586075 |
| 36 | TESK1 | 0.93684074 |
| 37 | NLK | 0.90699755 |
| 38 | HIPK2 | 0.89962943 |
| 39 | PIK3CG | 0.89616908 |
| 40 | EIF2AK3 | 0.89259709 |
| 41 | IKBKE | 0.87548333 |
| 42 | PDK3 | 0.85447038 |
| 43 | PDK4 | 0.85447038 |
| 44 | JAK1 | 0.84890372 |
| 45 | FLT3 | 0.83139840 |
| 46 | IRAK3 | 0.82970566 |
| 47 | TRPM7 | 0.81143255 |
| 48 | LRRK2 | 0.77988178 |
| 49 | SCYL2 | 0.77921565 |
| 50 | SGK2 | 0.76873152 |
| 51 | PRKCQ | 0.76254046 |
| 52 | SIK1 | 0.75243783 |
| 53 | TRIB3 | 0.74453681 |
| 54 | PRPF4B | 0.73303263 |
| 55 | FGFR3 | 0.72825943 |
| 56 | PRKD3 | 0.72557781 |
| 57 | SGK3 | 0.69499214 |
| 58 | MAPK7 | 0.68994113 |
| 59 | MAP3K14 | 0.67071697 |
| 60 | STK38 | 0.66664086 |
| 61 | NTRK1 | 0.63295653 |
| 62 | PIM2 | 0.61961526 |
| 63 | EPHA2 | 0.61604294 |
| 64 | DYRK1B | 0.60061983 |
| 65 | PDGFRB | 0.59558705 |
| 66 | ILK | 0.59223648 |
| 67 | PTK2 | 0.58603573 |
| 68 | PDGFRA | 0.57275102 |
| 69 | MAP2K6 | 0.56869283 |
| 70 | TAOK1 | 0.56151229 |
| 71 | FGFR1 | 0.55849782 |
| 72 | GSK3A | 0.55797096 |
| 73 | PRKCI | 0.53875867 |
| 74 | TYK2 | 0.52237058 |
| 75 | CDK8 | 0.50835068 |
| 76 | GRK7 | 0.50542617 |
| 77 | MELK | 0.49205954 |
| 78 | CHUK | 0.49179877 |
| 79 | JAK2 | 0.48894822 |
| 80 | TGFBR2 | 0.48581495 |
| 81 | FGFR4 | 0.47233519 |
| 82 | MAP3K1 | 0.46658006 |
| 83 | PAK3 | 0.44306695 |
| 84 | CDK6 | 0.42954378 |
| 85 | PRKCG | 0.42853324 |
| 86 | ITK | 0.41172471 |
| 87 | PRKG1 | 0.40822440 |
| 88 | GRK1 | 0.40780623 |
| 89 | IRAK2 | 0.40182760 |
| 90 | ERBB2 | 0.39823673 |
| 91 | MAPK12 | 0.39535206 |
| 92 | ZAP70 | 0.39366417 |
| 93 | LMTK2 | 0.39246720 |
| 94 | PRKAA1 | 0.37891073 |
| 95 | PRKCE | 0.37852290 |
| 96 | ERBB3 | 0.35883790 |
| 97 | KIT | 0.35697797 |
| 98 | EPHA3 | 0.35406720 |
| 99 | MAP3K5 | 0.34597507 |
| 100 | ROCK1 | 0.34310468 |
| 101 | PRKACA | 0.34275160 |
| 102 | EPHB1 | 0.34261519 |
| 103 | RIPK4 | 0.32873817 |
| 104 | PRKCD | 0.32485416 |
| 105 | AKT2 | 0.31609354 |
| 106 | MAP3K6 | 0.31465115 |
| 107 | PRKD2 | 0.30718380 |
| 108 | MAP2K2 | 0.30657411 |
| 109 | SGK1 | 0.29733023 |
| 110 | PDPK1 | 0.29242517 |
| 111 | BCR | 0.28953775 |
| 112 | NME1 | 0.28911051 |
| 113 | RIPK1 | 0.27725867 |
| 114 | CDC42BPA | 0.26369480 |
| 115 | MAP3K7 | 0.26323808 |
| 116 | NEK6 | 0.25280691 |
| 117 | PKN2 | 0.25241618 |
| 118 | TIE1 | 0.23943572 |
| 119 | PRKAA2 | 0.23759330 |
| 120 | RPS6KA2 | 0.23576213 |
| 121 | IRAK1 | 0.22933837 |
| 122 | BRD4 | 0.22900410 |
| 123 | MYLK | 0.21949043 |
| 124 | PRKD1 | 0.18780319 |
| 125 | PRKCH | 0.18234080 |
| 126 | PRKCA | 0.17746807 |
| 127 | EPHB2 | 0.17571243 |
| 128 | PRKACG | 0.17115312 |
| 129 | IGF1R | 0.17026549 |
| 130 | CAMKK2 | 0.16543000 |
| 131 | STK3 | 0.16260088 |
| 132 | PDK1 | 0.16087602 |
| 133 | PRKCZ | 0.14941279 |
| 134 | ERBB4 | 0.14556350 |
| 135 | PIK3CA | 0.14501474 |
| 136 | STK10 | 0.14479720 |
| 137 | RET | 0.14318724 |
| 138 | PINK1 | 0.14115046 |
| 139 | BTK | 0.12743440 |
| 140 | LIMK1 | 0.12603827 |
| 141 | CSNK1A1 | 0.10784875 |
| 142 | ADRBK1 | 0.10128523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.23489596 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.79381527 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.70987760 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.90980835 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.60862498 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.52530490 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.41445116 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.36082926 |
| 9 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.28883567 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.24314944 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.14861745 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.11461597 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.08247825 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.05590783 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03800446 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.99677476 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93189100 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.89991499 |
| 19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.82016435 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.80848851 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.76377630 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.65745381 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.62772161 |
| 24 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.62288454 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.58445354 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56111019 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.54432515 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52003866 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.43948776 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.43874888 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40613884 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.38033992 |
| 33 | Mineral absorption_Homo sapiens_hsa04978 | 1.37147619 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35883894 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35019093 |
| 36 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.34312580 |
| 37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.34199993 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33795917 |
| 39 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.29757249 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29186471 |
| 41 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.28818978 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18682870 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.17744376 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13747966 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.13407518 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.12692279 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08838462 |
| 48 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.08079752 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.06215777 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02490731 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01153950 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.01129495 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.00955537 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99773150 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99253407 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90810649 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 0.90438581 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90022830 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88638738 |
| 60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88165747 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.87625779 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86835213 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86611851 |
| 64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83425080 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78647689 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77913551 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76311822 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74994264 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71388118 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69751029 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.69230650 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66560679 |
| 73 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64680097 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64087676 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63603156 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62438475 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.61740940 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59714152 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59193245 |
| 80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59036380 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58371331 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.57371919 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56886946 |
| 84 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53581402 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53227922 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52875819 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52114132 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.51060964 |
| 89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46252514 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44234360 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44107121 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43436278 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.42579689 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41276614 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40464189 |
| 96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39977827 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37020924 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36842842 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34768145 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34746920 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31888681 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30820643 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.28987964 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28781059 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.28492265 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.26224204 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26177305 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.25398708 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.24607655 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.24172124 |
| 111 | Cocaine addiction_Homo sapiens_hsa05030 | 0.20400602 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.19390885 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.17360116 |
| 114 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.16259959 |
| 115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.14873849 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14733824 |
| 117 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.13120326 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.12844052 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12377338 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.11633044 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01258471 |
| 122 | TNF signaling pathway_Homo sapiens_hsa04668 | -0.0156114 |

